← Eichor
Study identifier: NCT04615065 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine

Condition: Acute Disease · Sepsis · Pneumonia  ·  Sponsor: University Medical Center Groningen

PhaseN/A
Planned participants35000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Research in acute care faces many challenges, including enrollment challenges, legal limitations in data sharing, limited funding, and lack of singular ownership of the domain of acute care. To overcome some of these challenges, the Center of Acute Care of the University Medical Center Groningen in the Netherlands, has established a de novo data-, image- and biobank named "Acutelines". Acutelines is initiated to improve recognition and treatment of acute diseases and obtain insight in the consequences of acute diseases, including factors predicting its outcome. Thereby, Acutelines contributes to development of personalized treatment and improves prediction of patient outcomes after an acute admission.

This description comes directly from the study's public registry record.

Talk to the study team

Hjalmar Bouma, MD, PhD  ·  +31 50 361 6161  ·  acutelines@umcg.nl

Always discuss trial participation with your own doctor first.

Locations (1)

University Medical Center GroningenGroningen, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04615065